ACUTE LYMPHOCYTIC LEUKEMIA
Clinical trials for ACUTE LYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells show promise against hard-to-treat childhood blood cancers
Disease control CompletedThis study tested a new treatment for children and young adults (ages 1-39) with B-cell leukemia or lymphoma that did not respond to standard therapy. Researchers took participants' white blood cells, modified them in a lab to target the CD22 protein on cancer cells, and infused …
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 12:07 UTC
-
New safety data for leukemia drug BESPONSA in 421 patients
Disease control CompletedThis study looked at the safety of BESPONSA, a drug already approved for a type of blood cancer called acute lymphocytic leukemia that has come back or not responded to treatment. Researchers tracked 421 patients in Japan who received the drug as part of their regular care. The m…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA
Sponsor: Pfizer • Aim: Disease control
Last updated May 19, 2026 11:46 UTC